Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Iranian strikes on Israel injure 11 and set chemical plant ablaze - 2Only 30% of young people in Israel optimistic about future, Aluma survey reveals
- 3Brazil's Bolsonaro to continue his sentence at home because of poor health
- 4Three arrested in Paris after attempted bomb attack outside Bank of America
- 5Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
- Scientists discover black hole flare with the light of 10 trillion suns
- Israel’s 'Stonehenge’ not alone with near 30 similar sites, satellite imagery reveals
- Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
- Inside the cockpit of RAF tanker during defensive mission against Iranian drones
- America's Confided in Cooler in 2024
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
- 6 Popular Ladies' Aromas On the planet
- Are Iraqi militias crossing into Iran to support Iran's war effort?
- 10 Demonstrated Systems to Develop Your Internet based Business
